MUMBAI, India, May 1 -- Intellectual Property India has published a patent application (202641049727 A) filed by Sr University, Warangal, Telangana, on April 18, for 'quantum-enabled nanoparticle systems for targeted drug delivery and controlled release.'
Inventor(s) include Dr. E. Purushotham; and Mr. Endla Akhil Balaji.
The application for the patent was published on May 1, under issue no. 18/2026.
According to the abstract released by the Intellectual Property India: "The current invention is associated with a Quantum-Enabled Nanoparticle System to Targeted Drug Delivery and Controlled Release, which is a combination of quantum-enabled nanomaterials and engineered nanoparticle carriers to enhance precision, efficiency, and safety in therapeutic applications. The invention is in the area of nanomedicine, biomedical engineering and precision therapeutics, and is intended to address shortcomings of conventional drug delivery systems, specifically, lack of specificity of targeting, premature drug release, and systemic toxicity. The system consists of a core nanoparticle that has been loaded with the drug and is then wrapped by a quantum-enabled functional layer and an outer layer that targets the drug. Quantum-enabled layer has nanostructures including quantum dots or quantum-confined materials that are more sensitive to biological stimuli and have better control of the drug release behavior. It is functionalized with targeting ligands such as antibodies, peptides, or aptamers on the outer shell to target diseased cells or tissues selectively. The nanoparticles will be engineered to be circulated effectively in the biological system with the help of a biocompatible stabilizer coating that minimizes immune response and increases systemic circulation. The release of drugs is regulated by internal physiological factors, e.g., pH, enzymes, or redox conditions and external stimuli, e.g., temperature, light, or electromagnetic. Quantum-enabled systems improve responsiveness, and allow fine-tuning of the release kinetics. Moreover, the system assists in real-time monitoring and adaptive control of drug delivery, enhancing the accuracy of therapeutic delivery and minimizing side effects. The invention offers an integrated platform that can have a combined targeted therapy, controlled release, and diagnostic tracking. On the whole, the invention provides a smart and scalable drug delivery platform that considerably improves the therapeutic efficacy and allows to apply new methods of cancer treatment, infectious diseases, and personalized medicine."
Disclaimer: Curated by HT Syndication.
